Balance Sheet Luye Pharma Group Ltd.

Equities

2186

BMG570071099

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:15 17/09/2024 BST			5-day change	1st Jan Change
2.960 ^HKD	+0.34%		0.00%	-20.64%

08-30	Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4	MT
08-28	Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

72bb9812938bc7bc473.Upe5sFelVru7e4K8lqG9N74hKPPOCnRgY3O56CfZGo4.E6PYhzvMBIj3Ie2I8P7iRYsRT532eEYuNRLVjE-XTukK5Ov3E9cejtEQ7Q

Published financial data: LUYE PHARMA GROUP LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	6.36B	5.54B	5.2B	5.98B	6.14B
Total Revenues	6.36B	5.54B	5.2B	5.98B	6.14B
Cost of Goods Sold, Total	1.48B	1.55B	1.8B	1.84B	1.94B
Gross Profit	4.88B	3.99B	3.4B	4.14B	4.2B
Selling General & Admin Expenses, Total	2.56B	2.19B	2.28B	2.4B	2.7B
Other Operating Expenses	589M	817M	758M	949M	617M
Other Operating Expenses, Total	3.15B	3B	3.03B	3.35B	3.32B
Operating Income	1.73B	988M	363M	789M	887M
Interest Expense, Total	-275M	-424M	-399M	-472M	-675M
Interest And Investment Income	142M	151M	190M	176M	210M
Net Interest Expenses	-133M	-273M	-210M	-296M	-465M
Income (Loss) On Equity Invest.	1.21M	1.73M	701K	831K	794K
Currency Exchange Gains (Loss)	21.1M	49.75M	-24.09M	106M	46.03M
Other Non Operating Income (Expenses)	133M	202M	130M	109M	242M
EBT, Excl. Unusual Items	1.75B	969M	260M	710M	711M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	9.4M	-3.46M	-14.81M	1.55M	1.94M
Gain (Loss) On Sale Of Assets	9.78M	87K	11.36M	-212K	1.5M
Legal Settlements	-	-	-273M	-14.07M	-14.52M
Other Unusual Items	-	-23.76M	-57.5M	-27.09M	633K
EBT, Incl. Unusual Items	1.77B	942M	-74.56M	670M	700M
Income Tax Expense	280M	239M	70.23M	86.47M	161M
Earnings From Continuing Operations	1.49B	703M	-145M	583M	539M
Net Income to Company	1.49B	703M	-145M	583M	539M
Minority Interest	-23.26M	3.32M	10.39M	21.51M	-6.47M
Net Income - (IS)	1.47B	707M	-134M	605M	533M
Net Income to Common Incl Extra Items	1.47B	707M	-134M	605M	533M
Net Income to Common Excl. Extra Items	1.47B	707M	-134M	605M	533M
Per Share Items
Net EPS - Basic	0.46	0.22	-0.04	0.17	0.14
Basic EPS - Continuing Operations	0.46	0.22	-0.04	0.17	0.14
Basic Weighted Average Shares Outstanding	3.2B	3.19B	3.45B	3.48B	3.73B
Net EPS - Diluted	0.45	0.22	-0.04	0.17	0.14
Diluted EPS - Continuing Operations	0.45	0.22	-0.04	0.17	0.14
Diluted Weighted Average Shares Outstanding	3.36B	3.19B	3.45B	3.48B	3.73B
Normalized Basic EPS	0.33	0.19	0.05	0.13	0.12
Normalized Diluted EPS	0.32	0.19	0.05	0.13	0.12
Dividend Per Share	0.11	-	-	-	-
Payout Ratio	25.66	24.84	-	-	-
Supplemental Items
EBITDA	2.14B	1.47B	907M	1.43B	1.55B
EBITA	1.93B	1.2B	598M	1.09B	1.2B
EBIT	1.73B	988M	363M	789M	887M
EBITDAR	2.16B	1.48B	922M	1.45B	1.57B
Effective Tax Rate - (Ratio)	15.79	25.36	-94.19	12.91	23
Total Current Taxes	286M	263M	104M	70.18M	200M
Total Deferred Taxes	-6.44M	-24.59M	-33.94M	16.29M	-39.18M
Normalized Net Income	1.07B	609M	173M	465M	438M
Interest on Long-Term Debt	62.49M	134M	133M	76.48M	68.67M
Non-Cash Pension Expense	94K	74K	63K	98K	127K
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.03B	1.66B	1.7B	1.82B	2.06B
General and Administrative Expenses	526M	521M	571M	583M	644M
Research And Development Expense From Footnotes	579M	790M	683M	857M	586M
Net Rental Expense, Total	12.9M	9.66M	14.93M	20.02M	17.93M
Imputed Operating Lease Interest Expense	3.99M	3.54M	4.9M	8.13M	11.05M
Imputed Operating Lease Depreciation	8.91M	6.12M	10.03M	11.89M	6.87M
Stock-Based Comp., Other (Total)	64.68M	51.25M	50.08M	25.44M	20.64M
Total Stock-Based Compensation	64.68M	51.25M	50.08M	25.44M	20.64M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	2.33B	3.87B	2.44B	2.32B	3.24B
Short Term Investments	1B	109M	388M	1.25B	1.27B
Trading Asset Securities, Total	552M	1.33B	2.68B	1.97B	1.6B
Total Cash And Short Term Investments	3.88B	5.31B	5.51B	5.54B	6.11B
Accounts Receivable, Total	1.7B	1.55B	1.77B	1.78B	2.35B
Other Receivables	124M	254M	623M	551M	321M
Total Receivables	1.83B	1.81B	2.39B	2.33B	2.68B
Inventory	615M	612M	746M	773M	828M
Prepaid Expenses	30.57M	93.7M	45.8M	-	94.13M
Restricted Cash	36.64M	37.47M	31.98M	32M	-
Other Current Assets, Total	2.97B	2.11B	1.67B	2.1B	999M
Total Current Assets	9.36B	9.97B	10.4B	10.79B	10.7B
Gross Property Plant And Equipment	4.5B	5.4B	5.85B	6.57B	7.42B
Accumulated Depreciation	-1.08B	-1.39B	-1.65B	-1.98B	-2.33B
Net Property Plant And Equipment	3.42B	4.02B	4.2B	4.59B	5.09B
Long-term Investments	71.87M	71.46M	582M	1.11B	1.97B
Goodwill	1.04B	1.06B	985M	1B	1.04B
Other Intangibles, Total	4.09B	3.76B	4.08B	4.45B	4.8B
Deferred Tax Assets Long-Term	93.86M	115M	133M	114M	145M
Deferred Charges Long-Term	395M	1.01B	1.36B	1.54B	1.51B
Other Long-Term Assets, Total	845M	632M	839M	658M	226M
Total Assets	19.31B	20.63B	22.58B	24.25B	25.49B
Liabilities
Accounts Payable, Total	298M	485M	571M	560M	767M
Accrued Expenses, Total	336M	210M	430M	686M	747M
Short-term Borrowings	3.72B	5.42B	4.74B	4.72B	4.57B
Current Portion of Long-Term Debt	211M	215M	501M	2.1B	609M
Current Portion of Leases	16.63M	13.01M	22.74M	15.25M	18.5M
Current Income Taxes Payable	204M	308M	141M	133M	200M
Unearned Revenue Current, Total	66.9M	131M	70.99M	72.82M	157M
Other Current Liabilities	697M	456M	854M	1.2B	1.07B
Total Current Liabilities	5.55B	7.23B	7.33B	9.49B	8.14B
Long-Term Debt	4.11B	4.33B	4.21B	2.24B	3.18B
Long-Term Leases	12.33M	11.73M	19.2M	23.24M	52.15M
Unearned Revenue Non Current	132M	186M	209M	384M	172M
Pension & Other Post Retirement Benefits	7.88M	8.08M	6.79M	2.02M	4.1M
Deferred Tax Liability Non Current	77.77M	74.32M	57.87M	56.03M	47.26M
Other Non Current Liabilities	55.81M	691M	1.64B	1.01B	373M
Total Liabilities	9.94B	12.53B	13.47B	13.21B	11.96B
Common Stock, Total	421M	418M	456M	457M	486M
Additional Paid In Capital	2.73B	1.04B	1.72B	3.08B	4.16B
Retained Earnings	5.92B	6.21B	6.06B	6.67B	7.38B
Treasury Stock	-280M	-280M	-280M	-280M	-
Comprehensive Income and Other	423M	502M	534M	254M	505M
Total Common Equity	9.22B	7.89B	8.49B	10.18B	12.53B
Minority Interest	148M	208M	626M	866M	997M
Total Equity	9.37B	8.1B	9.11B	11.04B	13.53B
Total Liabilities And Equity	19.31B	20.63B	22.58B	24.25B	25.49B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.2B	3.18B	3.54B	3.55B	3.76B
ECS Total Common Shares Outstanding	3.2B	3.18B	3.54B	3.55B	3.76B
Book Value / Share	2.88	2.48	2.4	2.87	3.33
Tangible Book Value	4.09B	3.07B	3.42B	4.72B	6.68B
Tangible Book Value Per Share	1.28	0.96	0.97	1.33	1.78
Total Debt	8.07B	9.98B	9.49B	9.1B	8.42B
Net Debt	4.19B	4.68B	3.98B	3.56B	2.32B
Debt Equivalent of Unfunded Proj. Benefit Obligation	7.88M	8.08M	6.79M	2.02M	4.1M
Debt Equivalent Oper. Leases	103M	77.26M	119M	160M	143M
Minority Interest, Total (Incl. Fin. Div)	148M	208M	626M	866M	997M
Equity Method Investments, Total	6.35M	8.64M	8.66M	7.78M	1.39B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	239M	221M	268M	316M	333M
Inventories - Work In Process, Total	126M	187M	219M	214M	235M
Inventories - Finished Goods, Total	250M	205M	259M	243M	260M
Land - (BS)	-	-	-	-	-
Buildings, Total	1.23B	1.46B	1.6B	1.71B	2.01B
Machinery, Total	2.34B	2.72B	3.03B	3.41B	3.64B
Full Time Employees	4.72K	4.96K	4.84K	5K	5.27K
Accumulated Allowance for Doubtful Accounts (Supple)	4.72M	4.17M	3.4M	3.33M	2.92M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	1.47B	707M	-134M	605M	533M
Depreciation & Amortization - CF	237M	296M	343M	367M	378M
Amortization of Goodwill and Intangible Assets - (CF)	201M	211M	234M	296M	316M
Depreciation & Amortization, Total	438M	506M	577M	663M	694M
Amortization of Deferred Charges, Total - (CF)	25.01M	6.35M	4.99M	7.86M	8.12M
(Gain) Loss From Sale Of Asset	-9.78M	-87K	-11.36M	212K	-1.5M
(Gain) Loss on Sale of Investments - (CF)	-9.4M	3.46M	14.81M	-1.55M	-1.94M
Asset Writedown & Restructuring Costs	6.88M	-	-	11.47M	-
(Income) Loss On Equity Investments - (CF)	-1.21M	-1.73M	-10.27M	-831K	-794K
Stock-Based Compensation (CF)	64.68M	50.9M	49.98M	25.44M	20.64M
Other Operating Activities, Total	51.99M	62.02M	110M	23.14M	-53.36M
Change In Accounts Receivable	-167M	145M	-212M	-18.77M	-571M
Change In Inventories	-29.01M	4.88M	-134M	-26.6M	-54.92M
Change In Accounts Payable	18.73M	144M	43.64M	-10.95M	207M
Change in Unearned Revenues	-36.42M	-16.86M	-6.43M	-42.47M	-74.87M
Change in Other Net Operating Assets	-76.31M	-578M	-109M	419M	891M
Cash from Operations	1.74B	1.03B	182M	1.65B	1.6B
Capital Expenditure	-970M	-693M	-556M	-656M	-633M
Sale of Property, Plant, and Equipment	256K	2.31M	13.77M	5.66M	3.17M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-2.24B	-732M	-985M	-508M	-533M
Investment in Marketable and Equity Securities, Total	389M	1.29B	-2.06B	-676M	-511M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	131M	266M	148M	175M	255M
Cash from Investing	-2.69B	138M	-3.44B	-1.66B	-1.42B
Short Term Debt Issued, Total	-	-	-	10.1M	4.96M
Long-Term Debt Issued, Total	8.85B	7.35B	7.16B	7.66B	8.08B
Total Debt Issued	8.85B	7.35B	7.16B	7.67B	8.08B
Short Term Debt Repaid, Total	-	-	-	-	-15.06M
Long-Term Debt Repaid, Total	-6.76B	-5.91B	-7.56B	-8.32B	-8.56B
Total Debt Repaid	-6.76B	-5.91B	-7.56B	-8.32B	-8.57B
Issuance of Common Stock	-	-	1.04B	-	923M
Repurchase of Common Stock	-8.78M	-77.96M	-	-	-
Common Dividends Paid	-377M	-175M	-	-	-
Common & Preferred Stock Dividends Paid	-377M	-175M	-	-	-
Other Financing Activities, Total	-97.86M	-933M	1.24B	710M	407M
Cash from Financing	1.61B	254M	1.88B	54.15M	842M
Foreign Exchange Rate Adjustments	-7.53M	112M	-52.37M	-164M	-104M
Net Change in Cash	653M	1.54B	-1.43B	-115M	915M
Supplemental Items
Cash Interest Paid	187M	330M	297M	369M	472M
Cash Income Tax Paid (Refund)	177M	160M	271M	92.77M	132M
Levered Free Cash Flow	-3.39B	400M	-779M	-43M	629M
Unlevered Free Cash Flow	-3.24B	663M	-529M	252M	1.05B
Change In Net Working Capital	1.62B	-908M	-154M	-225M	-939M
Net Debt Issued / Repaid	2.09B	1.44B	-406M	-656M	-488M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	5.87	3.09	1.05	2.11	2.23
Return on Total Capital	6.86	3.48	1.24	2.55	2.63
Return On Equity %	17.24	8.26	-1.68	5.79	4.39
Return on Common Equity	17.24	8.41	-1.64	6.48	4.69
Margin Analysis
Gross Profit Margin %	76.74	72.04	65.32	69.22	68.44
SG&A Margin	40.28	39.45	43.76	40.17	43.95
EBITDA Margin %	33.72	26.48	17.44	23.83	25.28
EBITA Margin %	30.37	21.64	11.49	18.15	19.58
EBIT Margin %	27.2	17.84	6.99	13.19	14.45
Income From Continuing Operations Margin %	23.47	12.7	-2.78	9.75	8.78
Net Income Margin %	23.1	12.76	-2.58	10.11	8.67
Net Avail. For Common Margin %